Revolutionary Saliva Test Validated for Endometriosis – Femtech Insider
Femtech Insider shared a post on LinkedIn:
“NEJM Evidence has published a validation study for Ziwig Biotech Endotest, a saliva-based diagnostic test for endometriosis. The study reports results from a prospective, independent, multicenter clinical trial conducted across 17 public and private hospitals in France.
The study reported sensitivity of 97.3%, specificity of 94.1%, overall accuracy of 96.6%, positive predictive value of 98.2%, and negative predictive value of 91.3%. Performance remained consistent across all subgroups, regardless of hormonal treatment, analgesic use, inclusion site, or sequencing conditions.
‘This publication in NEJM Evidence is a major step forward for science and for women affected by endometriosis. We are deeply grateful to all the women, hospitals, and healthcare professionals whose commitment and support have been essential in bringing this innovation to patients.’ Yahya EL MIR, Founder and President at Ziwig Biotech.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 13, 2026, 16:25Devyanshi Dixit: Building Healthier Futures Through Reproductive Health Education
-
Aug 13, 2026, 16:18Stephen Parker Ellington: An Encouraging Story for Fertility And Women’s Reproductive Choice
-
Aug 13, 2026, 16:09Kiani Davis: Fertility Patient Journey Series – Part 2
-
Aug 13, 2026, 16:02Lodovico Parmegiani: Live Births Following Universal Single-Step Warming Across Multiple Vitrification Systems
-
Aug 13, 2026, 15:51The Future of Women’s Health Begins With the Knowledge We Give Young People Today – GFWH 2026
-
Aug 13, 2026, 15:409 Affirmations from ECSACOG-CoP – FIGO
-
Aug 13, 2026, 15:29Devyanshi Dixit: Empowering Adolescents Through Reproductive and Menstrual Health Education
-
Aug 13, 2026, 15:23That’s a Wrap on the Fertility Society of Australia and New Zealand 2026 – Monash IVF Group
-
Aug 13, 2026, 15:18Devyanshi Dixit: Can Women Have Endometriosis Without Severe Pain?